A federal jury in California ruled Friday that Apple owes Masimo $634 million for infringing a blood-oxygen monitoring patent behind those little glowing sensors on your wrist. Trump canceling GDP ...

What just happened? Apple has been dealt a blow in its long-running patent battle against Masimo after a court ordered Cupertino to pay the health tech firm $634 million. The decision came on the same ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

A federal jury in the U.S. District Court for the Central District of California has ruled that Apple must pay $634 million to Masimo for allegedly infringing on a patent covering ‌blood-oxygen ...

In the latest chapter of the long-running legal war between Apple and medical tech company Masimo, a federal jury in California has ordered Apple to pay $634 million in damages. The jury found that ...

It hasn't even been a week since Apple reintroduced the blood oxygen feature to its US-based Apple Watch users. But Masimo has filed a lawsuit against US Customs and Border Protection (CBP), accusing ...

Following a decision that offered Apple a way to bring its Apple Watch blood oxygen tool back in the U.S., Bloomberg reports that Masimo alleges U.S. Customs and Border Protection "unlawfully let ...

Masimo (NASDAQ:MASI) filed a lawsuit against U.S. Customs and Border Protection over a decision that allowed Apple (NASDAQ:AAPL) to import Apple Watches with blood-oxygen feature technology during a ...

The medical tech company claims Customs helped Apple create a loophole in the ITC’s patent ruling. The medical tech company claims Customs helped Apple create a loophole in the ITC’s patent ruling. is ...

On Wednesday, Masimo filed a lawsuit in Washington, D.C., federal court, accusing Customs of improperly reversing its prior ruling without notifying the company, reported Reuters. The lawsuit comes ...